Skip to main content
logo
CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.980
-0.010 (-0.25%)
At close: Apr 17, 2026, 4:00 PM EDT
3.990
+0.010 (0.25%)
After-hours: Apr 17, 2026, 5:22 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Biotechnology (Startups)
4.01M9.74M7.14M
Biotechnology (Startups) Growth
-58.86%36.29%-
Total
4.01M9.74M7.14M
Total Growth
-58.86%36.29%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
United States
4.01M9.74M7.14M
United States Growth
-58.86%36.29%-
Total
4.01M9.74M7.14M
Total Growth
-58.86%36.29%-
Source: S&P Global Market Intelligence.